These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 20156413)

  • 21. A double-blind, randomized comparison of the efficacy and safety of intramuscular injections of olanzapine, lorazepam, or placebo in treating acutely agitated patients diagnosed with bipolar mania.
    Meehan K; Zhang F; David S; Tohen M; Janicak P; Small J; Koch M; Rizk R; Walker D; Tran P; Breier A
    J Clin Psychopharmacol; 2001 Aug; 21(4):389-97. PubMed ID: 11476123
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Injectable atypical antipsychotics for agitation in borderline personality disorder.
    Pascual JC; Madre M; Soler J; Barrachina J; Campins MJ; Alvarez E; Pérez V
    Pharmacopsychiatry; 2006 May; 39(3):117-8. PubMed ID: 16721704
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Double-blind, placebo-controlled comparison of intramuscular olanzapine and intramuscular haloperidol in the treatment of acute agitation in schizophrenia.
    Wright P; Birkett M; David SR; Meehan K; Ferchland I; Alaka KJ; Saunders JC; Krueger J; Bradley P; San L; Bernardo M; Reinstein M; Breier A
    Am J Psychiatry; 2001 Jul; 158(7):1149-51. PubMed ID: 11431240
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Potential complications of combining intramuscular olanzapine with benzodiazepines in emergency department patients.
    Wilson MP; MacDonald K; Vilke GM; Feifel D
    J Emerg Med; 2012 Nov; 43(5):889-96. PubMed ID: 20542400
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Olanzapine versus aripiprazole for the treatment of agitation in acutely ill patients with schizophrenia.
    Kinon BJ; Stauffer VL; Kollack-Walker S; Chen L; Sniadecki J
    J Clin Psychopharmacol; 2008 Dec; 28(6):601-7. PubMed ID: 19011427
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A Prospective Observational Study of Patients Receiving Intravenous and Intramuscular Olanzapine in the Emergency Department.
    Cole JB; Moore JC; Dolan BJ; O'Brien-Lambert A; Fryza BJ; Miner JR; Martel ML
    Ann Emerg Med; 2017 Mar; 69(3):327-336.e2. PubMed ID: 27823873
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Calming versus sedative effects of intramuscular olanzapine in agitated patients.
    Battaglia J; Lindborg SR; Alaka K; Meehan K; Wright P
    Am J Emerg Med; 2003 May; 21(3):192-8. PubMed ID: 12811711
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A naturalistic evaluation of intramuscular ziprasidone versus intramuscular olanzapine for the management of acute agitation and aggression in children and adolescents.
    Khan SS; Mican LM
    J Child Adolesc Psychopharmacol; 2006 Dec; 16(6):671-7. PubMed ID: 17201611
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhaled loxapine for agitation revisited: focus on effect sizes from 2 Phase III randomised controlled trials in persons with schizophrenia or bipolar disorder.
    Citrome L
    Int J Clin Pract; 2012 Mar; 66(3):318-25. PubMed ID: 22226343
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical perspectives on atypical antipsychotics for treatment of agitation.
    Caine ED
    J Clin Psychiatry; 2006; 67 Suppl 10():22-31. PubMed ID: 16965192
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intramuscular ziprasidone: moving beyond the conventional in the treatment of acute agitation in schizophrenia.
    Brook S
    J Clin Psychiatry; 2003; 64 Suppl 19():13-8. PubMed ID: 14728085
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Olanzapine: a review of rapid and long-acting parenteral formulations.
    Owen RT
    Drugs Today (Barc); 2010 Mar; 46(3):173-81. PubMed ID: 20467591
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A Large Retrospective Cohort of Patients Receiving Intravenous Olanzapine in the Emergency Department.
    Martel ML; Klein LR; Rivard RL; Cole JB
    Acad Emerg Med; 2016 Jan; 23(1):29-35. PubMed ID: 26720055
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intramuscular haloperidol versus intramuscular olanzapine for treatment of acute agitation: a cost-minimization study.
    Freeman DJ; DiPaula BA; Love RC
    Pharmacotherapy; 2009 Aug; 29(8):930-6. PubMed ID: 19637946
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A retrospective analysis of intramuscular haloperidol and intramuscular olanzapine in the treatment of agitation in drug- and alcohol-using patients.
    MacDonald K; Wilson MP; Minassian A; Vilke GM; Perez R; Cobb P; Tallian K; Becker O; Feifel D
    Gen Hosp Psychiatry; 2010; 32(4):443-5. PubMed ID: 20633750
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The efficacy of a rapid-acting intramuscular formulation of olanzapine for positive symptoms.
    Jones B; Taylor CC; Meehan K
    J Clin Psychiatry; 2001; 62 Suppl 2():22-4. PubMed ID: 11232747
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intramuscular aripiprazole in the acute management of psychomotor agitation.
    De Filippis S; Cuomo I; Lionetto L; Janiri D; Simmaco M; Caloro M; De Persis S; Piazzi G; Simonetti A; Telesforo CL; Sciarretta A; Caccia F; Gentile G; Kotzalidis GD; Girardi P
    Pharmacotherapy; 2013 Jun; 33(6):603-14. PubMed ID: 23505124
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Olanzapine in ED patients: differential effects on oxygenation in patients with alcohol intoxication.
    Wilson MP; Chen N; Vilke GM; Castillo EM; MacDonald KS; Minassian A
    Am J Emerg Med; 2012 Sep; 30(7):1196-201. PubMed ID: 22633728
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacological management of acute agitation.
    Battaglia J
    Drugs; 2005; 65(9):1207-22. PubMed ID: 15916448
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of rapidly acting intramuscular olanzapine, lorazepam, and placebo: a double-blind, randomized study in acutely agitated patients with dementia.
    Meehan KM; Wang H; David SR; Nisivoccia JR; Jones B; Beasley CM; Feldman PD; Mintzer JE; Beckett LM; Breier A
    Neuropsychopharmacology; 2002 Apr; 26(4):494-504. PubMed ID: 11927174
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.